DPP4 and gastrointestinal disease: For instance, activity of the endogenous proline-specific dipeptidyl peptidase-IV (DPP-IV) was shown to be reduced by an average of 70% in CeD patients compared to healthy individuals without gastrointestinal diseases (17), likely aggravating the indigestibility of GIPs and their accumulation.